299 filings
Page 10 of 15
8-K
zz2013lewdryt
7 Nov 12
Oncothyreon Reports Third Quarter 2012
12:00am
8-K
1u7x orbwnif
9 Aug 12
Oncothyreon Reports Second Quarter 2012
12:00am
8-K
nyftxc8uhj xkbn9h1v3
9 Aug 12
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
12:00am
8-K
ecnyqnww9h
21 Jun 12
Oncothyreon Announces Promotion of Scott Peterson, Ph.D., to Chief Scientific Officer
12:00am
8-K
5jgfeq2n
20 Jun 12
Submission of Matters to a Vote of Security Holders
12:00am
8-K
ktd6nuf
7 May 12
Oncothyreon Reports First Quarter 2012
12:00am
DEFA14A
4qgtm86bkfnzt0ew
25 Apr 12
Additional proxy soliciting materials
12:00am
8-K
8o046ru0szk1xwb41xa
3 Apr 12
Oncothyreon Announces Exercise of Underwriters’ Over-Allotment Option
12:00am
8-K
0hovzicqxg6jw1gn
29 Mar 12
Oncothyreon Prices $47.0 Million Public Offering of Common Stock
12:00am
8-K
m95nqjpnh n3
28 Mar 12
Oncothyreon Announces Proposed Public Offering of Common Stock
12:00am
8-K
dbgmv8olx18oey sb
6 Mar 12
Other Events
12:00am
8-K
iizz2ppk9
3 Feb 12
Entry into a Material Definitive Agreement
12:00am
8-K
db3h59jxw
5 Jan 12
Oncothyreon Announces Promotion of Diana Hausman, M.D., to Chief Medical Officer
12:00am